Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 19/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 19/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 19/20 | 0.53 |
| ▸ | HDAC6 | Q9UBN7 | 19/20 | 0.53 |
| ▸ | HDAC4 | P56524 | 18/20 | 0.53 |
| ▸ | HDAC7 | Q8WUI4 | 18/20 | 0.53 |
| ▸ | HDAC10 | Q969S8 | 18/20 | 0.53 |
| ▸ | HDAC11 | Q96DB2 | 18/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 18/20 | 0.53 |
| ▸ | HDAC9 | Q9UKV0 | 18/20 | 0.53 |
| ▸ | HDAC5 | Q9UQL6 | 18/20 | 0.53 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.45 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.45 |
| ▸ | ITGAL | P20701 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14557658 | 1.00 | HDAC3 (0.53) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL5151030 | 1.00 | HDAC3 (0.53) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL5151585 | 0.93 | HDAC3 (0.44) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL4601648 | 0.93 | HDAC3 (0.44) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL14564875 | 0.85 | ITGB2 (0.49) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL14557654 | 0.85 | ITGB2 (0.49) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL4601501 | 0.85 | HDAC3 (0.43) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL5151716 | 0.85 | HDAC3 (0.43) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL5151734 | 0.84 | HDAC3 (0.39) | HDAC3HDAC1HDAC2HDAC6HDAC4 | |
| SCHEMBL5151724 | 0.84 | HDAC3 (0.39) | HDAC3HDAC1HDAC2HDAC6HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1912970-A2 | ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL | Bayer Schering Pharma Aktiengesellschaft (DE) | 2008-04-23 | — | — | EP | claimed |
| US-20070060573-A1 | Acyltryptophanols | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-03-15 | — | — | US | claimed |
| WO-2007017289-A2 | ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-02-15 | — | — | WO | claimed |
| EP-1912970-A2 | ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL | Bayer Schering Pharma Aktiengesellschaft (DE) | 2008-04-23 | — | — | EP | disclosed |
| US-20070060573-A1 | Acyltryptophanols | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-03-15 | — | — | US | disclosed |
| WO-2007017289-A2 | ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-02-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070060573-A1 | Acyltryptophanols | FSHR, NPY1R, NPY2R | HDAC3 736/4885HDAC1 1530/4885HDAC2 1250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.